VIKTOR GRIBENKO: Open Payments
NPI 1659471944 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 16 payments from 9 companies in 2025. Trend: 2023 $1,095 · 2024 $702 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $554 |
| Astellas Pharma US Inc | 1 | $140 |
| Tandem Diabetes Care, Inc. | 3 | $138 |
| PFIZER INC. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Novo Nordisk Inc | 1 | $97 |
| Braeburn Inc. | 2 | $61 |
| Indivior Inc. | 1 | $28 |
Products named: QULIPTA, VRAYLAR, Veozah, t:slim X2 Insulin Pump with Control-IQ, UBRELVY, NURTEC ODT, XIFAXAN, BREZTRI.
Industry payments across NY — which companies pay providers there.
